Novexel has initiated Phase II clinical trial for advanced oral antibacterial NXL103 (flopristin/linopristin) in adults with acute bacterial skin and skin structure infections (ABSSSI). The trial is designed
Sagentia, a part of a consortium led by GlaxoSmithKline, is delivering a step change improvement in advanced secondary pharmaceutical manufacturing in the UK. The aim of the project
GlaxoSmithKline Biologicals (GSK) has received prequalification from the World Health Organization (WHO) for global use to Synflorix, pneumococcal conjugate vaccine. The WHO prequalification allows UN agencies to purchase
Aurobindo Pharma (Aurobindo) has received the final approval for Lamotrigine tablets (chewable, dispersible) 5mg and 25mg from the FDA. Lamotrigine tablets 5mg and 25mg is generic equivalent to
Ziopharm has presented positive interim data from the multicenter randomized Phase II trial of palifosfamide (Zymafos, ZIO-201) treating patients with unresectable or metastatic soft tissue sarcoma. The randomized
GlaxoSmithKline (GSK) and XenoPort has reported that the FDA has extended the original Prescription Drug User Fee Act (PDUFA) goal date for its review of the New Drug
PPD has completed its acquisition of Excel, a contract research organisation in China. The acquisition strengthens PPD’s full range of drug development services in the country and positions
Calbiotech has received a Small Business Innovative Research (SBIR) Phase I contract by the US Army Medical Research and Material command. Under terms of the agreement, Calbiotech is
Chimerix has presented updates on the development of the antiviral compound, CMX001, to the World Health Organization (WHO) and the Global Health Security Initiative (GHSI). CMX001 is a
Intarcia has presented data for ITCA 650 (DUROS continuous delivery of exenatide) program for the treatment of type 2 diabetes at the Ninth Annual Diabetes Technology Meeting in
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.